NCT06194188 - A Phase 2 Clinical Study of CU-20401 | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

September 2, 2024

Study Completion Date

September 2, 2024

Conditions

Efficacy and Safety

Interventions

DRUG

Subcutaneous injection of CU-20401

Reconstitute the product with 0.9% sodium chloride solution for injection, respectively, before use, for a single subcutaneous injection in the submental fat area.

Trial Locations (1)

430000

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan